Screening of concurrent α-thalassaemia 1 in β-thalassaemia carriers

Medical Journal of Malaysia

Volumn 61, Issue 2, 2006, Pages 217-220

  Chong, Y M ^a   Tan, J A M A ^b   Zubaidah, Z ^c   Rahimah, A ^c   Kuldip, K ^c   George, E ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c Institute for Medical Research   (Serbia)

Author keywords

Concurrent carriers; Gene interaction; Screening; Thalassaemia

Indexed keywords

ALPHA THALASSEMIA; ALPHA THALASSEMIA 1 GENE; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DISEASE CARRIER; DNA DETERMINATION; DNA EXTRACTION; FREQUENCY ANALYSIS; GENE; GENE DELETION; GENE FREQUENCY; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; POLYMERASE CHAIN REACTION; PUBLIC HEALTH;

ALPHA-THALASSEMIA; BETA-THALASSEMIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEMOGLOBINS; HUMANS; MALAYSIA; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 33746382227     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. George E. Beta-thalassemia major in Malaysia, an Ongoing Public Health Problem. Med J Malaysia 2001; 60(1): 397-400.
2. Wasi P. Haemoglobinopathies including thalassaemia. In: Luzzato L. Haematology in tropical areas. Clinics in Haematology. Philadelphia. WB Saunders Company Ltd. 1981; 10: 707-29.
3. Weatherall DJ, Clegg JB. (2001) Public Health Reviews: Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 2001; 79: 704-12.
4. George E, Jamal AR, Faridah K, Kamarul AO. High performance liquid chromatography (HPLC) as a screening tool for classical beta-thalassaemia trait in Malaysia. Malaysian Journal of Medical Sciences 2001; 8 : 40-6.
5. Ma ESK, Chan AYY, Ha SY, Chan FCC, Lau YL, Chan LC. Screening for (-SEA) a-globin gene deletion in b-thalassaemia carriers and prevention of hydrops fetalis. Haematologica 2000; 85: 991-93.
6. Ma ESK, Chan AYY, Chan LC, Au WY, Yeung YM. Diagnosis of concurrent hemoglobin H disease and heterozygous b-thalassaemia. Haematologica 2001; 86: 432-33.
7. British Committee of Standards in Haematology. The laboratory diagnosis of haemoglobinopathies. British Journal of Haematology 1998; 101: 783-92.
8. Lwanga SK, Lemeshow S. Sample size determination in health studies. World Health Organization, Geneva. 1991; 25.
9. Han J, Zeng R, Hu B. The prevalence of beta-thalassemia heterozygotes compound alpha-thalassemia in Guangdong district. Zhonghua Xue Ye Xue Za Zhi 2001; 10: 514-17 [Article in Chinese]
10. Winichagoon P, Fucharoen S, Kanokpongsakdi S, Fukumaki Y. 1995 Detection of a-thalassaemia-1 (Southeast Asian type) and its application for prenatal diagnosis. Clinical Genetics 1995; 47: 318-20
11. Chung SW, Wong SC, Clarke BJ, Patterson M, Walker WHC, Chui DHK. 1984 Human embryonic z-globin chains in adult patients with a-thalassemias. Proceedings of the National Academy of Sciences of the United States of America 1984; 81: 6188-90.
12. Tang W, Luo HY, Albitar M, Patterson M, Eng B, Waye JS, Liebhaber SA, Higgs DR, Chui DHK. Human embryonic z-globin chain expression in deletional a-thalassemias. Blood 1992; 80: 517-22.
13. Lau YL, Chan LC, Chan AYY, Ha SY, Yeung CY, Waye JS, Chui DHK. 1997 Prevalence and genotypes of a- and b-thalassaemia carriers in Hong Kong - implications for population screening. The New Engl J Med 1997; 336: 1298-301.
14. Cao A. William Allan award address. American J of Human Genet 1994; 54: 397-402.
15. Modell B, Kuliev AM. 1993 A scientific basis for cost-benefit analysis of genetics services. Trends of Genetics 1993; 9: 46-52.